Gastrointestinal Agents Market 2027 By Drug Class, Distribution Channel, and Geography | The Insight Partners

Gastrointestinal Agents Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Drug Class (Antidiarrheal, Anti-Emetics, Anti-Ulcers, Laxatives, Others); Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Others); and Geography

Report Code: TIPRE00018110 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
Covid
MARKET INTRODUCTION

Gastrointestinal agents refers to the drugs which are used to control gastrointestinal activities such as gastric acidity and to regulate the process of digestion. These agents can be classified into acidifiers, antacids, adsorbents, and laxatives.

MARKET DYNAMICS

The gastrointestinal agents market is expected to witness considerable growth due to significant prevalence of gastrointestinal issues and rising awareness about gastrointestinal agents. However, stringent government regulations are expected to hamper the growth of the global gastrointestinal agents market.

MARKET SCOPE

The "Gastrointestinal Agents Market Analysis to 2027" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of Gastrointestinal Agents Market with detailed market segmentation by drug class and distribution channel. The Gastrointestinal Agents Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Gastrointestinal Agents Market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The gastrointestinal agents market is segmented on the basis of drug class and distribution channel. Based on drug class, the market segmented as antidiarrheal, anti-emetics, anti-ulcers, laxatives, and others. Based on distribution channel, the market is segmented as hospital pharmacies, retail pharmacies, and others.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Gastrointestinal Agents Market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Gastrointestinal Agents Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Gastrointestinal Agents Market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Gastrointestinal Agents Market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the Gastrointestinal Agents Market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Gastrointestinal Agents Market are anticipated to have lucrative growth opportunities in the future with the rising demand for smart hospital beds in the global market. Below mentioned is the list of few companies engaged in the Gastrointestinal Agents Market.

The report also includes the profiles of key players in Gastrointestinal Agents Market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •  Abbott Laboratories
  •  Allergan Plc.
  •  AstraZeneca
  •  Bayer AG
  •  Boehringer Ingelheim GmbH
  •  GlaxoSmithKline plc.
  •  Janssen Biotech, Inc.
  •  Ranbaxy Laboratories Limited
  •  Sanofi
  •  Takeda Pharmaceutical

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Gastrointestinal Agents Market - By Drug Class
1.3.2 Gastrointestinal Agents Market - By Distribution Channel
1.3.3 Gastrointestinal Agents Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. GASTROINTESTINAL AGENTS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. GASTROINTESTINAL AGENTS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. GASTROINTESTINAL AGENTS MARKET - GLOBAL MARKET ANALYSIS
6.1. GASTROINTESTINAL AGENTS - GLOBAL MARKET OVERVIEW
6.2. GASTROINTESTINAL AGENTS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. GASTROINTESTINAL AGENTS MARKET - REVENUE AND FORECASTS TO 2027 - DRUG CLASS
7.1. OVERVIEW
7.2. DRUG CLASS MARKET FORECASTS AND ANALYSIS
7.3. ANTIDIARRHEAL
7.3.1. Overview
7.3.2. Antidiarrheal Market Forecast and Analysis
7.4. ANTI-EMETICS
7.4.1. Overview
7.4.2. Anti-Emetics Market Forecast and Analysis
7.5. ANTI-ULCERS
7.5.1. Overview
7.5.2. Anti-Ulcers Market Forecast and Analysis
7.6. LAXATIVES
7.6.1. Overview
7.6.2. Laxatives Market Forecast and Analysis
7.7. OTHERS
7.7.1. Overview
7.7.2. Others Market Forecast and Analysis
8. GASTROINTESTINAL AGENTS MARKET - REVENUE AND FORECASTS TO 2027 - DISTRIBUTION CHANNEL
8.1. OVERVIEW
8.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
8.3. HOSPITAL PHARMACIES
8.3.1. Overview
8.3.2. Hospital Pharmacies Market Forecast and Analysis
8.4. RETAIL PHARMACIES
8.4.1. Overview
8.4.2. Retail Pharmacies Market Forecast and Analysis
8.5. OTHERS
8.5.1. Overview
8.5.2. Others Market Forecast and Analysis
9. GASTROINTESTINAL AGENTS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Gastrointestinal Agents Market Overview
9.1.2 North America Gastrointestinal Agents Market Forecasts and Analysis
9.1.3 North America Gastrointestinal Agents Market Forecasts and Analysis - By Drug Class
9.1.4 North America Gastrointestinal Agents Market Forecasts and Analysis - By Distribution Channel
9.1.5 North America Gastrointestinal Agents Market Forecasts and Analysis - By Countries
9.1.5.1 United States Gastrointestinal Agents Market
9.1.5.1.1 United States Gastrointestinal Agents Market by Drug Class
9.1.5.1.2 United States Gastrointestinal Agents Market by Distribution Channel
9.1.5.2 Canada Gastrointestinal Agents Market
9.1.5.2.1 Canada Gastrointestinal Agents Market by Drug Class
9.1.5.2.2 Canada Gastrointestinal Agents Market by Distribution Channel
9.1.5.3 Mexico Gastrointestinal Agents Market
9.1.5.3.1 Mexico Gastrointestinal Agents Market by Drug Class
9.1.5.3.2 Mexico Gastrointestinal Agents Market by Distribution Channel
9.2. EUROPE
9.2.1 Europe Gastrointestinal Agents Market Overview
9.2.2 Europe Gastrointestinal Agents Market Forecasts and Analysis
9.2.3 Europe Gastrointestinal Agents Market Forecasts and Analysis - By Drug Class
9.2.4 Europe Gastrointestinal Agents Market Forecasts and Analysis - By Distribution Channel
9.2.5 Europe Gastrointestinal Agents Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Gastrointestinal Agents Market
9.2.5.1.1 Germany Gastrointestinal Agents Market by Drug Class
9.2.5.1.2 Germany Gastrointestinal Agents Market by Distribution Channel
9.2.5.2 France Gastrointestinal Agents Market
9.2.5.2.1 France Gastrointestinal Agents Market by Drug Class
9.2.5.2.2 France Gastrointestinal Agents Market by Distribution Channel
9.2.5.3 Italy Gastrointestinal Agents Market
9.2.5.3.1 Italy Gastrointestinal Agents Market by Drug Class
9.2.5.3.2 Italy Gastrointestinal Agents Market by Distribution Channel
9.2.5.4 Spain Gastrointestinal Agents Market
9.2.5.4.1 Spain Gastrointestinal Agents Market by Drug Class
9.2.5.4.2 Spain Gastrointestinal Agents Market by Distribution Channel
9.2.5.5 United Kingdom Gastrointestinal Agents Market
9.2.5.5.1 United Kingdom Gastrointestinal Agents Market by Drug Class
9.2.5.5.2 United Kingdom Gastrointestinal Agents Market by Distribution Channel
9.2.5.6 Rest of Europe Gastrointestinal Agents Market
9.2.5.6.1 Rest of Europe Gastrointestinal Agents Market by Drug Class
9.2.5.6.2 Rest of Europe Gastrointestinal Agents Market by Distribution Channel
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Gastrointestinal Agents Market Overview
9.3.2 Asia-Pacific Gastrointestinal Agents Market Forecasts and Analysis
9.3.3 Asia-Pacific Gastrointestinal Agents Market Forecasts and Analysis - By Drug Class
9.3.4 Asia-Pacific Gastrointestinal Agents Market Forecasts and Analysis - By Distribution Channel
9.3.5 Asia-Pacific Gastrointestinal Agents Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Gastrointestinal Agents Market
9.3.5.1.1 Australia Gastrointestinal Agents Market by Drug Class
9.3.5.1.2 Australia Gastrointestinal Agents Market by Distribution Channel
9.3.5.2 China Gastrointestinal Agents Market
9.3.5.2.1 China Gastrointestinal Agents Market by Drug Class
9.3.5.2.2 China Gastrointestinal Agents Market by Distribution Channel
9.3.5.3 India Gastrointestinal Agents Market
9.3.5.3.1 India Gastrointestinal Agents Market by Drug Class
9.3.5.3.2 India Gastrointestinal Agents Market by Distribution Channel
9.3.5.4 Japan Gastrointestinal Agents Market
9.3.5.4.1 Japan Gastrointestinal Agents Market by Drug Class
9.3.5.4.2 Japan Gastrointestinal Agents Market by Distribution Channel
9.3.5.5 South Korea Gastrointestinal Agents Market
9.3.5.5.1 South Korea Gastrointestinal Agents Market by Drug Class
9.3.5.5.2 South Korea Gastrointestinal Agents Market by Distribution Channel
9.3.5.6 Rest of Asia-Pacific Gastrointestinal Agents Market
9.3.5.6.1 Rest of Asia-Pacific Gastrointestinal Agents Market by Drug Class
9.3.5.6.2 Rest of Asia-Pacific Gastrointestinal Agents Market by Distribution Channel
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Gastrointestinal Agents Market Overview
9.4.2 Middle East and Africa Gastrointestinal Agents Market Forecasts and Analysis
9.4.3 Middle East and Africa Gastrointestinal Agents Market Forecasts and Analysis - By Drug Class
9.4.4 Middle East and Africa Gastrointestinal Agents Market Forecasts and Analysis - By Distribution Channel
9.4.5 Middle East and Africa Gastrointestinal Agents Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Gastrointestinal Agents Market
9.4.5.1.1 South Africa Gastrointestinal Agents Market by Drug Class
9.4.5.1.2 South Africa Gastrointestinal Agents Market by Distribution Channel
9.4.5.2 Saudi Arabia Gastrointestinal Agents Market
9.4.5.2.1 Saudi Arabia Gastrointestinal Agents Market by Drug Class
9.4.5.2.2 Saudi Arabia Gastrointestinal Agents Market by Distribution Channel
9.4.5.3 U.A.E Gastrointestinal Agents Market
9.4.5.3.1 U.A.E Gastrointestinal Agents Market by Drug Class
9.4.5.3.2 U.A.E Gastrointestinal Agents Market by Distribution Channel
9.4.5.4 Rest of Middle East and Africa Gastrointestinal Agents Market
9.4.5.4.1 Rest of Middle East and Africa Gastrointestinal Agents Market by Drug Class
9.4.5.4.2 Rest of Middle East and Africa Gastrointestinal Agents Market by Distribution Channel
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Gastrointestinal Agents Market Overview
9.5.2 South and Central America Gastrointestinal Agents Market Forecasts and Analysis
9.5.3 South and Central America Gastrointestinal Agents Market Forecasts and Analysis - By Drug Class
9.5.4 South and Central America Gastrointestinal Agents Market Forecasts and Analysis - By Distribution Channel
9.5.5 South and Central America Gastrointestinal Agents Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Gastrointestinal Agents Market
9.5.5.1.1 Brazil Gastrointestinal Agents Market by Drug Class
9.5.5.1.2 Brazil Gastrointestinal Agents Market by Distribution Channel
9.5.5.2 Argentina Gastrointestinal Agents Market
9.5.5.2.1 Argentina Gastrointestinal Agents Market by Drug Class
9.5.5.2.2 Argentina Gastrointestinal Agents Market by Distribution Channel
9.5.5.3 Rest of South and Central America Gastrointestinal Agents Market
9.5.5.3.1 Rest of South and Central America Gastrointestinal Agents Market by Drug Class
9.5.5.3.2 Rest of South and Central America Gastrointestinal Agents Market by Distribution Channel
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL GASTROINTESTINAL AGENTS MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Middle East and Africa
10.5 South and Central America
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. GASTROINTESTINAL AGENTS MARKET, KEY COMPANY PROFILES
12.1. ABBOTT LABORATORIES
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. ALLERGAN PLC.
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. ASTRAZENECA
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. BAYER AG
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. BOEHRINGER INGELHEIM GMBH
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. GLAXOSMITHKLINE PLC.
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. JANSSEN BIOTECH, INC.
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. RANBAXY LABORATORIES LIMITED
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. SANOFI
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. TAKEDA PHARMACEUTICAL
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS

The List of Companies

1. Abbott Laboratories
2. Allergan Plc.
3. AstraZeneca
4. Bayer AG
5. Boehringer Ingelheim GmbH
6. GlaxoSmithKline plc.
7. Janssen Biotech, Inc.
8. Ranbaxy Laboratories Limited
9. Sanofi
10. Takeda Pharmaceutical
TIPRE00018110
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking